<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font25 { font-size : 25; } .font26 { font-size : 26; } .font27 { font-size : 27; } .font28 { font-size : 28; } .font29 { font-size : 29; } .font30 { font-size : 30; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">PvDBP_RII </span>
   <span class="font30">responses </span>
   <span class="font29">protein </span>
   <span class="font28">Plasmodium </span>
   <span class="font28">vivax </span>
   <span class="font27">using </span>
   <span class="font27">vaccine </span>
   <span class="font26">mice </span>
   <span class="font25">binding </span>
   <span class="font23">malaria </span>
   <span class="font23">immunization </span>
   <span class="font22">antigen </span>
   <span class="font21">IgG </span>
   <span class="font21">immunized </span>
   <span class="font21">recombinant </span>
   <span class="font20">human </span>
   <span class="font20">cell </span>
   <span class="font19">antibodies </span>
   <span class="font19">vaccines </span>
   <span class="font19">clinical </span>
   <span class="font19">serum </span>
   <span class="font19">vectors </span>
   <span class="font18">falciparum </span>
   <span class="font18">viral </span>
   <span class="font18">antibody </span>
   <span class="font17">previously </span>
   <span class="font17">regimes </span>
   <span class="font17">immunogenicity </span>
   <span class="font17"> weeks </span>
   <span class="font17">MVA </span>
   <span class="font17">inhibition </span>
   <span class="font17">vectored </span>
   <span class="font16">PPP </span>
   <span class="font16">SC, </span>
   <span class="font16">assay </span>
   <span class="font16">blood-stage </span>
   <span class="font16">induced </span>
   <span class="font16">regime </span>
   <span class="font16">described </span>
   <span class="font16">shown </span>
   <span class="font16">used </span>
   <span class="font15">BALB/c </span>
   <span class="font15">ChAd </span>
   <span class="font15">Duffy </span>
   <span class="font15">adenovirus </span>
   <span class="font15">cells </span>
   <span class="font15">data </span>
   <span class="font15">following </span>
   <span class="font15">titers </span>
   <span class="font15">(Figure </span>
   <span class="font15">invasion </span>
   <span class="font14">Figure </span>
   <span class="font14">HAdV </span>
   <span class="font14">Med </span>
   <span class="font14">adenoviral </span>
   <span class="font14">antigens </span>
   <span class="font14">expressing </span>
   <span class="font14">Abisco </span>
   <span class="font14">Montanide </span>
   <span class="font14">Vaccine </span>
   <span class="font14">final </span>
   <span class="font14">peptides </span>
   <span class="font14">sera </span>
   <span class="font14">vector </span>
   <span class="font14">IFN-γ </span>
   <span class="font14">control </span>
   <span class="font14">immune </span>
   <span class="font14">observed </span>
   <span class="font14">response </span>
   <span class="font14">studies </span>
   <span class="font14">tested </span>
   <span class="font13">Chitnis </span>
   <span class="font13">Phase </span>
   <span class="font13">infection </span>
   <span class="font13">samples </span>
   <span class="font13">ELISA </span>
   <span class="font13">MVA-PvDBP_RII </span>
   <span class="font13">Research </span>
   <span class="font13">SJ, </span>
   <span class="font13">adjuvants </span>
   <span class="font13">boost </span>
   <span class="font13">day </span>
   <span class="font13">development </span>
   <span class="font13">different </span>
   <span class="font13">formulated </span>
   <span class="font13">performed </span>
   <span class="font13">reported </span>
   <span class="font13">significant </span>
   <span class="font13">trials </span>
   <span class="font13">AR, </span>
   <span class="font13">DARC </span>
   <span class="font13">Draper </span>
   <span class="font13">HAdV-PvDBP_RII </span>
   <span class="font13">Immunol </span>
   <span class="font13">OLP </span>
   <span class="font13">ability </span>
   <span class="font13">assessed </span>
   <span class="font13">based </span>
   <span class="font13">boosted </span>
   <span class="font13">comparison </span>
   <span class="font13">followed </span>
   <span class="font13">generated </span>
   <span class="font13">immunity </span>
   <span class="font13">induce </span>
   <span class="font13">levels </span>
   <span class="font13">marker </span>
   <span class="font13">measured </span>
   <span class="font13">parasite </span>
   <span class="font13">versus </span>
   <span class="font12">AP, </span>
   <span class="font12">Biswas </span>
   <span class="font12">Infect </span>
   <span class="font12">candidate </span>
   <span class="font12">cellular </span>
   <span class="font12">dilution </span>
   <span class="font12">gene </span>
   <span class="font12">harvested </span>
   <span class="font12">individual </span>
   <span class="font12">induction </span>
   <span class="font12">mouse </span>
   <span class="font12">rDBP </span>
   <span class="font12">rabbits </span>
   <span class="font12">sample </span>
   <span class="font12">shown. </span>
   <span class="font12">similar </span>
   <span class="font12">vitro </span>
   <span class="font12"> μg/mL </span>
   <span class="font12">(A) </span>
   <span class="font12">CE, </span>
   <span class="font12">Development </span>
   <span class="font12">IgGa </span>
   <span class="font12">Immun </span>
   <span class="font12">PvDBP_RII, </span>
   <span class="font12">Serum </span>
   <span class="font12">Shakri </span>
   <span class="font12">[./journal.pone.] </span>
   <span class="font12">adjuvant </span>
   <span class="font12">anti-PvDBP_RII </span>
   <span class="font12">chimpanzee </span>
   <span class="font12">comparable </span>
   <span class="font12">encoding </span>
   <span class="font12">later </span>
   <span class="font12">peptide </span>
   <span class="font12">subunit </span>
   <span class="font12">units </span>
   <span class="font12">vaccine-induced </span>
   <span class="font12">virus </span>
   <span class="font12">vivo </span>
   <span class="font12">®ISA </span>
   <span class="font12"> days </span>
   <span class="font12">AD, </span>
   <span class="font12">AM, </span>
   <span class="font12">Douglas </span>
   <span class="font12">Elias </span>
   <span class="font12">Goodman </span>
   <span class="font12">Malaria </span>
   <span class="font12">Mol </span>
   <span class="font12">PvDBP </span>
   <span class="font12">P = ., </span>
   <span class="font12">Sci </span>
   <span class="font12">UK) </span>
   <span class="font12">[./IAI.-] </span>
   <span class="font12">[./j.vaccine...] </span>
   <span class="font12">added </span>
   <span class="font12">assessment </span>
   <span class="font12">blood </span>
   <span class="font12">candidates </span>
   <span class="font12">capable </span>
   <span class="font12">context </span>
   <span class="font12">high-titer </span>
   <span class="font12">humoral </span>
   <span class="font12">immunizations </span>
   <span class="font12">inhibit </span>
   <span class="font12">inhibitory </span>
   <span class="font12">leading </span>
   <span class="font12">macaques </span>
   <span class="font12">phase </span>
   <span class="font12">priming </span>
   <span class="font12">protein-in-adjuvant </span>
   <span class="font12">receptor </span>
   <span class="font12">region </span>
   <span class="font12">rhesus </span>
   <span class="font12">sequence </span>
   <span class="font12">showed </span>
   <span class="font12">simian </span>
   <span class="font12">staining </span>
   <span class="font12">trial </span>
   <span class="font12">vaccination </span>
   <span class="font11">AL, </span>
   <span class="font11">Cassan </span>
   <span class="font11">Collins </span>
   <span class="font11">Duffy-binding </span>
   <span class="font11">ELISpot </span>
   <span class="font11">Following </span>
   <span class="font11">Gilbert </span>
   <span class="font11">KA, </span>
   <span class="font11">Median </span>
   <span class="font11">Nat </span>
   <span class="font11">PvDBP_RII. </span>
   <span class="font11">SH, </span>
   <span class="font11">Trop </span>
   <span class="font11">Vaccines </span>
   <span class="font11">Wellcome </span>
   <span class="font11">achieved </span>
   <span class="font11">acquired </span>
   <span class="font11">anti-mouse </span>
   <span class="font11">antigen-specific </span>
   <span class="font11">associated </span>
   <span class="font11">compared </span>
   <span class="font11">delivery </span>
   <span class="font11">erythrocytes </span>
   <span class="font11">humans </span>
   <span class="font11">immunization, </span>
   <span class="font11">infected </span>
   <span class="font11">isotype </span>
   <span class="font11">median </span>
   <span class="font11">native </span>
   <span class="font11">number </span>
   <span class="font11">preclinical </span>
   <span class="font11">prime-boost </span>
   <span class="font11">prior </span>
   <span class="font11">protection </span>
   <span class="font11">purified </span>
   <span class="font11">re-stimulation </span>
   <span class="font11">recent </span>
   <span class="font11">safety </span>
   <span class="font11">spleen </span>
   <span class="font11">strong </span>
   <span class="font11">supported </span>
   <span class="font11">targeting </span>
   <span class="font11">test </span>
   <span class="font11">total </span>
   <span class="font11"> pfu </span>
   <span class="font11">(B) </span>
   <span class="font11">A). </span>
   <span class="font11">AV, </span>
   <span class="font11">CJ, </span>
   <span class="font11">Cells </span>
   <span class="font11">Clinical </span>
   <span class="font11">Duncan </span>
   <span class="font11">Ewer </span>
   <span class="font11">Fellowship </span>
   <span class="font11">GFP </span>
   <span class="font11">Hill </span>
   <span class="font11">IFA </span>
   <span class="font11">Kruskal–Wallis </span>
   <span class="font11">Mann–Whitney </span>
   <span class="font11">Miller </span>
   <span class="font11">OVA </span>
   <span class="font11">PBS </span>
   <span class="font11">Parasitol </span>
   <span class="font11">Rev </span>
   <span class="font11">SS, </span>
   <span class="font11">Singapore </span>
   <span class="font11">Ther </span>
   <span class="font11">Trust </span>
   <span class="font11">UK). </span>
   <span class="font11">University </span>
   <span class="font11">Yazdani </span>
   <span class="font11">[./jimmunol.] </span>
   <span class="font11">[./mt..] </span>
   <span class="font11">approach </span>
   <span class="font11">assess </span>
   <span class="font11">concentration </span>
   <span class="font11">confirmed </span>
   <span class="font11">containing </span>
   <span class="font11">diluted </span>
   <span class="font11">effect </span>
   <span class="font11">efficacy </span>
   <span class="font11">elicited </span>
   <span class="font11">endpoint </span>
   <span class="font11">erythrocyte </span>
   <span class="font11">expression </span>
   <span class="font11">flow </span>
   <span class="font11">frozen </span>
   <span class="font11">heterologous </span>
   <span class="font11">however, </span>
   <span class="font11">immunization. </span>
   <span class="font11">immunogenic </span>
   <span class="font11">interaction </span>
   <span class="font11">knowlesi </span>
   <span class="font11">largely </span>
   <span class="font11">merozoite </span>
   <span class="font11">multiple </span>
   <span class="font11">natural </span>
   <span class="font11">n = ) </span>
   <span class="font11">plates </span>
   <span class="font11">pool </span>
   <span class="font11">positive </span>
   <span class="font11">previous </span>
   <span class="font11">protein. </span>
   <span class="font11">rabbit </span>
   <span class="font11">reference </span>
   <span class="font11">regimes, </span>
   <span class="font11">significantly </span>
   <span class="font11">splenocytes </span>
   <span class="font11">standard </span>
   <span class="font11">stated </span>
   <span class="font11">suggest </span>
   <span class="font11">surface </span>
   <span class="font11">taken </span>
   <span class="font11">vaccines, </span>
   <span class="font11">washed </span>
   <span class="font11"> ifu </span>
   <span class="font11"> μg </span>
   <span class="font11">(BD </span>
   <span class="font11">(C) </span>
   <span class="font11">(D) </span>
   <span class="font11">(PP) </span>
   <span class="font11">(day </span>
   <span class="font11">Antibodies </span>
   <span class="font11">Binding </span>
   <span class="font11">CA, </span>
   <span class="font11">CL, </span>
   <span class="font11">Capone </span>
   <span class="font11">Commun </span>
   <span class="font11">Dicks </span>
   <span class="font11">Duffy-negative </span>
   <span class="font11">Here, </span>
   <span class="font11">ISA </span>
   <span class="font11">Indirect </span>
   <span class="font11">Individual </span>
   <span class="font11">KJ, </span>
   <span class="font11">LH, </span>
   <span class="font11">MD, </span>
   <span class="font11">MRC </span>
   <span class="font11">Medical </span>
   <span class="font11">Miura </span>
   <span class="font11">Program </span>
   <span class="font11">RD, </span>
   <span class="font11">RT. </span>
   <span class="font11">Results </span>
   <span class="font11">Sheehy </span>
   <span class="font11">Singh </span>
   <span class="font11">[./ncomms] </span>
   <span class="font11">according </span>
   <span class="font11">acids </span>
   <span class="font11">adenovirus-MVA </span>
   <span class="font11">adjuvant. </span>
   <span class="font11">agreement </span>
   <span class="font11">amino </span>
   <span class="font11">analysis </span>
   <span class="font11">assay. </span>
   <span class="font11">assayed </span>
   <span class="font11">assays </span>
   <span class="font11">background </span>
   <span class="font11">better </span>
   <span class="font11">carried </span>
   <span class="font11">case </span>
   <span class="font11">cases </span>
   <span class="font11">cells, </span>
   <span class="font11">clinically </span>
   <span class="font11">compatible </span>
   <span class="font11">complete </span>
   <span class="font11">conserved </span>
   <span class="font11">determined </span>
   <span class="font11">developed </span>
   <span class="font11">disease </span>
   <span class="font11">domain </span>
   <span class="font11">doses </span>
   <span class="font11">epitopes </span>
   <span class="font11">exposure </span>
   <span class="font11">functional </span>
   <span class="font11">goat </span>
   <span class="font11">highest </span>
   <span class="font11">humans. </span>
   <span class="font11">i.m. </span>
   <span class="font11">included </span>
   <span class="font11">including </span>
   <span class="font11">indicates </span>
   <span class="font11">inhibiting </span>
   <span class="font11">line </span>
   <span class="font11">low </span>
   <span class="font11">mice. </span>
   <span class="font11">model </span>
   <span class="font11">montanide </span>
   <span class="font11">naïve </span>
   <span class="font11">numerous </span>
   <span class="font11">n = –/group) </span>
   <span class="font11">patients </span>
   <span class="font11">platforms </span>
   <span class="font11">points </span>
   <span class="font11">potent </span>
   <span class="font11">poxviral </span>
   <span class="font11">poxvirus </span>
   <span class="font11">prime </span>
   <span class="font11">produced </span>
   <span class="font11">progressed </span>
   <span class="font11">protective </span>
   <span class="font11">rabbits, </span>
   <span class="font11">re-stimulated </span>
   <span class="font11">receptor-binding </span>
   <span class="font11">report </span>
   <span class="font11">responses, </span>
   <span class="font11">seen </span>
   <span class="font11">serotype </span>
   <span class="font11">slides </span>
   <span class="font11">target </span>
   <span class="font11">testing </span>
   <span class="font11">titer </span>
   <span class="font11">use </span>
   <span class="font11">use, </span>
   <span class="font11">vaccination. </span>
   <span class="font11">vaccinia </span>
   <span class="font11">vivax, </span>
   <span class="font11">®ISA. </span>
   <span class="font11"> ×  </span>
  </p>
 </body>
</html>
